Form D · Biotechnology
IFM Quattro, Inc.
Boston, MA · CIK 0001796904
Offering snapshot reported Dec 17, 2019 · SEC filing
- Reported sold
- $5M Indefinite offering
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 25, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 17, 2019 | Initial | $5,000,002 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-355693
Source: Form D, filed Dec 17, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Shelley Chu | Director |
| Jean Francois Formela | Director |
| Gary Glick | Director, Executive |
| John Leonard | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
855 Boylston Street, 11 Th Floor
Boston, MA, 02116
Boston, MA, 02116